Fresenius Medical Care AG (FMS) Invested Capital (2016 - 2025)

Fresenius Medical Care AG (FMS) has 16 years of Invested Capital data on record, last reported at $32.2 billion in Q4 2025.

  • For Q4 2025, Invested Capital rose 12.7% year-over-year to $32.2 billion; the TTM value through Dec 2025 reached $32.2 billion, up 12.7%, while the annual FY2025 figure was $31.3 billion, 8.0% up from the prior year.
  • Invested Capital reached $32.2 billion in Q4 2025 per FMS's latest filing, up from $28.6 billion in the prior quarter.
  • Across five years, Invested Capital topped out at $32.2 billion in Q4 2025 and bottomed at $16.4 billion in Q4 2022.
  • Average Invested Capital over 4 years is $27.1 billion, with a median of $29.9 billion recorded in 2024.
  • Peak YoY movement for Invested Capital: soared 111.33% in 2021, then plummeted 47.42% in 2022.
  • A 4-year view of Invested Capital shows it stood at $31.2 billion in 2021, then tumbled by 47.42% to $16.4 billion in 2022, then surged by 74.14% to $28.6 billion in 2024, then rose by 12.7% to $32.2 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Invested Capital were $32.2 billion in Q4 2025, $28.6 billion in Q4 2024, and $16.4 billion in Q4 2022.